USE OF INTERLEUKIN-27 AS A DIAGNOSTIC BIOMARKER FOR BACTERIAL INFECTION IN CRITICALLY ILL PATIENTS

摘要

Embodiments of the invention are directed to methods of diagnosing bacterial infection in a critically ill patient. The methods include obtaining a sample from the patient and determining the patient's level of IL-27 expression. Embodiments of the invention are also directed to methods that include determining both the patient's levels of IL-27 expression and PCT expression and using the combined result to provide a diagnosis of bacterial infection in a critically ill patient.